Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Leukemia|January 18, 2020
Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AMLMelanie Kahl, Annamaria Brioli, Martin Bens, et al.Journal of Cancer Research and Clinical Oncology|August 8, 2018
Diverging impact of cell fate determinants Scrib and Llgl1 on adhesion and migration of hematopoietic stem cellsBanaja P Dash, Tina M Schnöder, Carolin Kathner, et al.Cell Death & Disease|August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiationHans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.Leukemia|September 1, 2021
YBX1 mediates translation of oncogenic transcripts to control cell competition in AMLFlorian Perner, Tina M Schnoeder, Yijun Xiong, et al.Blood|September 22, 2020
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosisPeter G Miller, Adam S Sperling, Christopher J Gibson, et al.Nature|March 16, 2023
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemiaGhayas C Issa, Ibrahim Aldoss, John DiPersio, et al.Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.Cancer Discovery|October 20, 2022
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL InhibitionYadira M Soto-Feliciano, Francisco J Sánchez-Rivera, Florian Perner, et al.Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.Pageof 4